Economic Evaluation of Timely Versus Delayed Use of Tumor Necrosis Factor Inhibitors for Treatment of Psoriatic Arthritis in the US
Crossref DOI link: https://doi.org/10.1007/s40744-016-0042-2
Published Online: 2016-09-15
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Strand, Vibeke
Husni, Elaine
Griffith, Jenny
Zhou, Zheng-Yi
Signorovitch, James
Ganguli, Arijit
Funding for this research was provided by:
AbbVie